Therefore, these data showed that ZD55-IL-24 could also increase the levels of anti-angiogenic factors and decrease the levels of pro-angiogenic factors in tumors, which result in inhibition of angiogenesis, further contributing to the anti-melanoma efficacy of ZD55-IL-24 in B16-bearing immunocompetent mouse model. The gene discussed is IL24; the disease is melanoma.